Delivery Order SPE2DU25D9415-SPE2DU26FEJDE
Award Date 5/6/26
Potential Completion Date 5/7/26
Potential Value $14K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $14,374.20 delivery order to DMS Pharmaceutical Group Inc. on April 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to military healthcare facilities. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. DMS Pharmaceutical Group Inc. is a woman-owned small business authorized...
- The Defense Logistics Agency issued a $1,642.44 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on May 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to Department of Defense military healthcare facilities. PPV-G GEN V is a single-award indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036. DMS Pharmaceutical is the sole regional prime vendor authorized to...
- The Defense Logistics Agency issued a $9,940.80 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on May 6, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to defense medical facilities. PPV-G GEN V is a $30.3 billion acquisition strategy structured as a single-award indefinite delivery contract framework through which DMS Pharmaceutical serves as the sole regional prime vendor authorized to issue firm...
- The Defense Logistics Agency issued a $7,140.18 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on April 13, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499.999 billion ceiling, authorized to issue firm fixed-price delivery...
- The Defense Logistics Agency issued a $1,039.50 delivery order to DMS Pharmaceutical Group Inc. on April 20, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling supporting Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical is a woman-owned small business authorized as the sole regional...
- The Defense Logistics Agency issued a $43,929.03 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on April 1, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract for pharmaceutical distribution to support Department of Defense medical supply needs. The PPV-G GEN V is a Defense Logistics Agency single-award IDC with a $499.999 billion ceiling and ultimate completion through December 31, 2036. It...
- The Defense Logistics Agency issued a $1,720.60 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on April 6, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support...
- The Defense Logistics Agency issued a $7,594.65 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 17, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. PPV-G GEN V is a $30.3 billion Defense Logistics Agency acquisition strategy establishing multiple regional prime vendor contractors to supply branded and generic prescription drugs, over-the-counter medications, biologics, vaccines,...
- The Defense Logistics Agency issued a $4,405.20 delivery order to DMS Pharmaceutical Group Inc. on May 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to Department of Defense military healthcare facilities. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036. DMS Pharmaceutical is the sole regional prime vendor authorized to issue...
- The Defense Logistics Agency issued a $17,628.86 delivery order to DMS Pharmaceutical Group Inc. on April 21, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to military healthcare facilities. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. DMS Pharmaceutical Group Inc. is a woman-owned small business and the sole regional prime...